Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
EWTX
#1558
Edgewise Therapeutics, Inc. Common Stock
33.160
0
USD
-2.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.01%
Monthly Change
+11.39%
6 month change
+117.73%
Year Change
+117.73%
Previous Close
33.840
0
Open
33.160
0
Bid
Ask
Low
33.160
0
High
33.160
0
Volume
79
Markets
US Stock Market
Healthcare
EWTX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
49.51 M
63.26 M
93.11 M
95.21 M
107.27 M
—
Valuation ratios
Enterprise value
740.98 M
534.08 M
938.12 M
2.5 B
2.6 B
7.87 B
Price to earnings ratio
-13.4
-6.98
-7.01
-18.41
-15.22
-48.14
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-17.11
-8.95
-7.62
-22.63
-17.76
-57.56
Price to book ratio
2.09
1.36
2.2
5.37
4.89
7.42
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.15
-0.18
-0.29
-0.27
-0.3
-0.31
Return on equity %
-0.16
-0.2
-0.31
-0.29
-0.32
-0.33
Return on invested capital %
-65.99
-96.33
-158.55
-187.92
-168.3
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
26.97
21.53
19.5
19.93
19.85
96.22
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.89
-0.98
-1.44
-1.18
-1.4
-1.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.41
0.41
1.35
0.45
0.59
1.97
Net current asset value per share
7.56
6.66
5.13
5.15
5.28
21.13
Tangible book value per share
7.31
6.47
5
4.97
5.07
20.5
Working capital per share
7.28
6.35
4.87
4.89
5.01
20.23
Book value per share
7.31
6.47
5
4.97
5.07
20.5
News
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
JPMorgan raises Edgewise Therapeutics price target on pipeline outlook
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock after trial data
Truist reiterates Edgewise Therapeutics stock rating on trial data
Edgewise reports functional stability in Becker dystrophy trial
Evercore ISI raises Edgewise Therapeutics price target on HCM data
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock
Stifel raises Edgewise Therapeutics stock price target on trial data timeline
Edgewise Therapeutics stock hits 52-week high at $31.39
Edgewise Therapeutics earnings on deck as pipeline advances
Edgewise Therapeutics stock hits 52-week high at $30.26
Piper Sandler reiterates Overweight rating on Edgewise Therapeutics stock